Pharmacokinetics of single and multiple oral doses of zd 1839 (‘Iressa’), a specific epidermal growth factor receptor tyrosine kinase inhibitor (egfr-tki), in healthy male volunteers
- 30 April 2001
- journal article
- abstracts
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 37, S67
- https://doi.org/10.1016/s0959-8049(01)80728-0